ArticleAdvances in simulation (London, England)2022
Developing a simulation safety policy for translational simulation programs in healthcare.
Article in Advances in simulation (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Health and safety considerations for healthcare simulation: a scoping review of published literature.Advances in simulation (London, England) · 2026Article
- Addressing under-appreciated risk in healthcare simulation.Advances in simulation (London, England) · 2026Article
- Stop play: key takeaways on physical safety awareness in healthcare simulation education.Advances in simulation (London, England) · 2026Article
- Combining forces to improve simulation-based practices for Emergency Preparedness and Disaster Responses.Advances in simulation (London, England) · 2025Article
- Translational simulation revisited: an evolving conceptual model for the contribution of simulation to healthcare quality and safety.Advances in simulation (London, England) · 2024Article
- Developing a competency framework for training with simulations in healthcare: a qualitative study.BMC medical education · 2024Review
- Faculty development for translational simulation: a qualitative study of current practice.Advances in simulation (London, England) · 2023Article
- In situ simulation-based team training and its significance for transfer of learning to clinical practice-A qualitative focus group interview study of anaesthesia personnel.BMC medical education · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Healthcare simulation may present risks to safety, especially when delivered 'in situ'-in real clinical environments-when lines between simulated and real practice may be blurred. We felt compelled to develop a simulation safety policy (SSP) after reading reports of adverse events in the healthcare simulation literature, editorials highlighting these safety risks, and reflecting on our own experience as a busy translational simulation service in a large healthcare institution.The process for development of a comprehensive SSP for translational simulation programs is unclear. Personal correspondence with leaders of simulation programs like our own revealed a piecemeal approach in most institutions. In this article, we describe the process we used to develop the simulation safety policy at our health service, and crystalize principles that may provide guidance to simulation programs with similar challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.